Espinosa, Jason T.

HRN: 26-51-25  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/11/2025
01/19/2025
IV
1.5gm
Tid
Pneumonia
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: